Format

Send to

Choose Destination
Biochem Biophys Res Commun. 2003 Oct 17;310(2):567-73.

C-terminal pro-ghrelin peptides are present in the human circulation.

Author information

1
Christchurch Cardioendocrine Research Group, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand. chris.pemberton@chmeds.ac.nz

Abstract

We provide the first evidence for the existence in human plasma of peptides derived from the 66 carboxyl-terminal amino acids of pro-ghrelin (C-ghrelin). C-ghrelin immunoreactivity in plasma was higher than ghrelin, and did not significantly correlate with body mass index in normal health. In patients with myocardial infarction, plasma levels of both ghrelin and C-ghrelin were significantly decreased (approximately 30%, P<0.05), whereas in patients with heart failure, C-ghrelin levels were significantly elevated (approximately 32%, P<0.05) compared with controls. HPLC coupled with RIA showed circulating C-ghrelin to be primarily of low molecular weight (M(r) approximately 3500), but in chronic heart failure, a higher molecular weight form (M(r) approximately 7500) is also present. This is the first evidence for potential circulating hormones derived from the carboxyl terminus of pro-ghrelin and for their modulation in cardiovascular diseases.

PMID:
14521948
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center